These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 17241926

  • 1. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.
    Tay J, Tinmouth A, Fergusson D, Huebsch L, Allan DS.
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):206-17. PubMed ID: 17241926
    [Abstract] [Full Text] [Related]

  • 2. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
    Cheuk DK, Chiang AK, Ha SY, Chan GC.
    Cochrane Database Syst Rev; 2015 May 27; 2015(5):CD009311. PubMed ID: 26017019
    [Abstract] [Full Text] [Related]

  • 3. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
    Hassan Z.
    Pediatr Transplant; 2010 Sep 01; 14(6):683-7. PubMed ID: 20353406
    [No Abstract] [Full Text] [Related]

  • 4. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?
    Johnson DB, Savani BN.
    Exp Hematol; 2012 Jul 01; 40(7):513-7. PubMed ID: 22542577
    [Abstract] [Full Text] [Related]

  • 5. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Imran H, Tleyjeh IM, Zirakzadeh A, Rodriguez V, Khan SP.
    Bone Marrow Transplant; 2006 Apr 01; 37(7):677-86. PubMed ID: 16489362
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Kashyap R, Anwer F, Iqbal MA, Khalid F, Khan A, Ali MA, Anwar MY, Chaudhary A, Jaan A.
    Hematol Oncol Stem Cell Ther; 2023 Jan 17; 16(2):93-101. PubMed ID: 34655527
    [Abstract] [Full Text] [Related]

  • 9. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.
    Essell JH, Schroeder MT, Harman GS, Halvorson R, Lew V, Callander N, Snyder M, Lewis SK, Allerton JP, Thompson JM.
    Ann Intern Med; 1998 Jun 15; 128(12 Pt 1):975-81. PubMed ID: 9625683
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
    Gökce M, Kuskonmaz B, Cetin M, Uckan Cetinkaya D, Tuncer M.
    Exp Clin Transplant; 2013 Oct 15; 11(5):440-6. PubMed ID: 24128137
    [Abstract] [Full Text] [Related]

  • 12. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation.
    Br J Haematol; 2013 Nov 15; 163(4):444-57. PubMed ID: 24102514
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
    Qin CJ, Liu LJ, Zhang ZM, Luo L, Lai YR, Li QC.
    Zhonghua Nei Ke Za Zhi; 2018 Jul 01; 57(7):483-486. PubMed ID: 29996265
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
    Lakshminarayanan S, Sahdev I, Goyal M, Vlachos A, Atlas M, Lipton JM.
    Pediatr Transplant; 2010 Aug 01; 14(5):618-21. PubMed ID: 20051023
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.